This inventor holds 1 USPTO granted patent. Top assignee: Toa Eiyo Ltd.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: **Innovative Contributions of Rie Yorita in Pharmaceutical Chemistry**
Introduction
Rie Yorita, an accomplished inventor based in Fukushima, Japan, has made notable strides in the field of pharmaceutical chemistry. With a keen focus on developing chemical compounds, she has contributed significantly to innovations that hold promise for medical applications.
Latest Patents
Yorita holds a patent for cycloheptenopyridine derivatives, which presents a novel process for preparing these compounds. The cycloheptenopyridine derivatives are represented by a complex general formula, where various groups can be substituted, enhancing their potential functionality. These derivatives and their salts are particularly useful as antiulcer agents, showcasing Yorita's commitment to advancing therapeutic options in medicine.
Career Highlights
Throughout her career, Rie Yorita has focused on research and innovation in drug development. Her work at Toa Eiyo Ltd. reflects her dedication to creating valuable pharmaceutical solutions. With one patent to her name, she exemplifies the spirit of invention in the pharmaceutical industry, contributing to the broader goal of improving health outcomes.
Collaborations
Yorita has worked alongside esteemed colleagues Shin-ichi Yamada and Takao Goto. These collaborations not only augment the scope of her research but also highlight the collective effort in the pursuit of medical advancements. Working with her peers, she has been able to merge different areas of expertise, fostering an environment of innovation.
Conclusion
Rie Yorita's innovative work and patent contributions have marked her as a noteworthy figure in the field of pharmaceutical chemistry. Her developments, particularly in cycloheptenopyridine derivatives, hold promise for advancing treatment options in the medical field. As she continues her work at Toa Eiyo Ltd., Rie Yorita remains a vital player in the landscape of pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile